XG SCIENCES INC
company.status.inactiveCIK 1435375fmd_1250KX99C8EGVGT8W7WEBNZAGMManufacturing · Plastic Materials, Synth Resins & Nonvulcan ElastomersTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2020, 24 periods
Latest annual · FY2020
Millions- Total revenues
- 1
- Gross profit
- (2)
- Operating income
- (7)
- Net income
- (7)
- Free cash flow
- (5)
Latest quarter · Q4 FY2020
Millions- Total revenues
- 0
- Gross profit
- (1)
- Operating income
- (2)
- Net income
- (1)
- Free cash flow
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2017 to FY2020
- -24.3%
- Revenue, 5 yearsFY2015 to FY2020
- +4.0%
- Net income, 5 yearsFY2015 to FY2020
- n/m
XG SCIENCES INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2020 | FY2019 | Change | Source |
|---|---|---|---|---|
| Revenue | $782,692 | $1.4 million | -42.9% | 10-K 2021-09-30 · proof |
| Gross profit | -$1.9 million | -$2.4 million | 10-K 2021-09-30 · proof | |
| Operating income | -$7 million | -$9.4 million | 10-K 2021-09-30 · proof | |
| Net income | -$7.1 million | -$9.8 million | 10-K 2021-09-30 · proof | |
| Cash from operating activities | -$4.8 million | -$8.6 million | 10-K 2021-09-30 · proof | |
| Free cash flow | -$4.8 million | -$9 million | 10-K 2021-09-30 · proof | |
| Total assets | $7.4 million | $8.5 million | -13.9% | 10-K 2021-09-30 · proof |
| Total liabilities | $15 million | $10.7 million | +40.7% | 10-K 2021-09-30 · proof |
| Cash and cash equivalents | $1.8 million | $1.1 million | +57.1% | 10-K 2021-09-30 · proof |
| Total debt | $12.8 million | 10-K 2021-09-30 · proof |
- What was XG SCIENCES INC's revenue in fiscal 2020?
- XG SCIENCES INC reported revenue of $782,692 for fiscal 2020 (the year ended Dec 31, 2020), against $1.4 million the year before (-42.9%). Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What was XG SCIENCES INC's gross profit in fiscal 2020?
- XG SCIENCES INC reported gross profit of -$1.9 million for fiscal 2020 (the year ended Dec 31, 2020), against -$2.4 million the year before. Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What was XG SCIENCES INC's operating income in fiscal 2020?
- XG SCIENCES INC reported operating income of -$7 million for fiscal 2020 (the year ended Dec 31, 2020), against -$9.4 million the year before. Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What was XG SCIENCES INC's net income in fiscal 2020?
- XG SCIENCES INC reported net income of -$7.1 million for fiscal 2020 (the year ended Dec 31, 2020), against -$9.8 million the year before. Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What was XG SCIENCES INC's cash from operating activities in fiscal 2020?
- XG SCIENCES INC reported cash from operating activities of -$4.8 million for fiscal 2020 (the year ended Dec 31, 2020), against -$8.6 million the year before. Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What was XG SCIENCES INC's free cash flow in fiscal 2020?
- XG SCIENCES INC reported free cash flow of -$4.8 million for fiscal 2020 (the year ended Dec 31, 2020), against -$9 million the year before. Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What are XG SCIENCES INC's total assets?
- As of Dec 31, 2020, XG SCIENCES INC reported total assets of $7.4 million, against $8.5 million a year earlier (-13.9%). Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What are XG SCIENCES INC's total liabilities?
- As of Dec 31, 2020, XG SCIENCES INC reported total liabilities of $15 million, against $10.7 million a year earlier (+40.7%). Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What are XG SCIENCES INC's cash and cash equivalents?
- As of Dec 31, 2020, XG SCIENCES INC reported cash and cash equivalents of $1.8 million, against $1.1 million a year earlier (+57.1%). Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What is XG SCIENCES INC's total debt?
- As of Dec 31, 2020, XG SCIENCES INC reported total debt of $12.8 million. Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1435375&period_type=annual&limit=5"Information only, not investment advice.